Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"It is silly (but sort of predictable) to make a case either pro or against IPIX based on what little we know."

I'm not sure what case you're trying to dismiss. The issue being considered wasn't "a case either pro or against IPIX based on what little we know". It was whether an exclusivity clause was likely to exist (per a poster: "...90% of the time...even a Non-binding term sheet will contain a time restriction during which acquirer has at least 90 days to complete DD and the target company cannot talk to or negotiate with any other potential acquirer.") and, if so, would that be a good or a bad thing for IPIX. As you said "For instance, if a term sheet has an exclusivity clause then there can't be other term sheets or negotiations over same drug in parallel."
I said it seemed not to be in IPIX's interest for such an agreement to exist and you instantly dismissed the case. This issue shares elements with the questions about who held the cards in the milestone agreement.

Personally I don't believe the "90% of the time" representation. That said, a global pharmaceutical company probably wouldn't get much resistance if it wanted to impose an exclusivity clause under the circumstances. As you say, "Well, who has the money?". I wonder if one could expect such an agreement to preclude the global pharmaceutical company from pursuing agreements with other companies that have drug candidates for the same indications. Please comment, unless that case got closed, too.